Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Albumin in Ischemic Stroke (MOZEG)
NCT07415655Phase 2Recruiting
- Sponsor
- Fakultní nemocnice Hradec Králové
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in ischemic stroke, sponsored by Fakultní nemocnice Hradec Králové. Started Feb 2026; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07415655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07415655.